These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 8751956)

  • 21. [Salivary antibodies of Sonnei dysentery reconvalescents and healthy subjects with different probable risks of infection by Shigellae].
    Khazenson LB; Kolesnikova EN; Bogolapova NI
    Zh Mikrobiol Epidemiol Immunobiol; 1981 Jan; (1):43-9. PubMed ID: 7015762
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Safety and immunogenicity of an oral, inactivated, whole-cell vaccine for Shigella sonnei: preclinical studies and a Phase I trial.
    McKenzie R; Walker RI; Nabors GS; Van De Verg LL; Carpenter C; Gomes G; Forbes E; Tian JH; Yang HH; Pace JL; Jackson WJ; Bourgeois AL
    Vaccine; 2006 May; 24(18):3735-45. PubMed ID: 16095766
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antibody response to Shigella sonnei infection determined by an enzyme-linked immunosorbent assay.
    Ekwall E; Haeggmann S; Kalin M; Svenungsson B; Lindberg AA
    Eur J Clin Microbiol; 1983 Jun; 2(3):200-5. PubMed ID: 6349988
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Nonspecific nature of antibody formation suppression by virulent Shigella sonnei].
    Borisov VA; Frolov AF
    Mikrobiol Zh (1978); 1982; 44(1):71-6. PubMed ID: 7040918
    [No Abstract]   [Full Text] [Related]  

  • 25. [The determination in saliva of IgA antibodies to Shigella ribosomes for the diagnosis of dysentery].
    Salamatova SA; Sukhoroslova LI; Chernokhvostova EV; Levenson VI
    Zh Mikrobiol Epidemiol Immunobiol; 1991 Jun; (6):59-62. PubMed ID: 1887713
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dissecting the contribution of O-Antigen and proteins to the immunogenicity of Shigella sonnei generalized modules for membrane antigens (GMMA).
    Mancini F; Gasperini G; Rossi O; Aruta MG; Raso MM; Alfini R; Biagini M; Necchi F; Micoli F
    Sci Rep; 2021 Jan; 11(1):906. PubMed ID: 33441861
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Sociodemographic factors associated with serum anti-Shigella lipopolysaccharide antibodies and shigellosis.
    Cohen D; Slepon R; Green MS
    Int J Epidemiol; 1991 Jun; 20(2):546-50. PubMed ID: 1917263
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Concentration of milk secretory immunoglobulin A against Shigella virulence plasmid-associated antigens as a predictor of symptom status in Shigella-infected breast-fed infants.
    Hayani KC; Guerrero ML; Morrow AL; Gomez HF; Winsor DK; Ruiz-Palacios GM; Cleary TG
    J Pediatr; 1992 Dec; 121(6):852-6. PubMed ID: 1447644
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Characteristics of Shigella sonnei infection of volunteers: signs, symptoms, immune responses, changes in selected cytokines and acute-phase substances.
    Munoz C; Baqar S; van de Verg L; Thupari J; Goldblum S; Olson JG; Taylor DN; Heresi GP; Murphy JR
    Am J Trop Med Hyg; 1995 Jul; 53(1):47-54. PubMed ID: 7542845
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Studies of antibody against Shigella in bacillary dysentery patients and carriers. Report 4. Comparison of the results obtained from IgG antibody absorption with protein A-sepharose CL-4B and from those with indirect radioimmunoassay (author's transl)].
    Miyata Y
    Kansenshogaku Zasshi; 1977 Oct; 51(10):540-9. PubMed ID: 101599
    [No Abstract]   [Full Text] [Related]  

  • 31. [Specific antigens of the causative agents and their antibodies in the circulating immune complexes in acute dysentery].
    Bunin KV; Iusova GA; Kravtsov EG; Belaia OF; Vaĭsbord NG
    Zh Mikrobiol Epidemiol Immunobiol; 1985 Aug; (8):78-80. PubMed ID: 2414952
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Immunoglobulin and antibody content in the blood serum, coprofiltrate and saliva of patients with Sonne dysentery].
    Kuz'min SN; Belaia IuA; Kul'berg AIa; Sukhoroslova LI; Mel'nik ZG
    Zh Mikrobiol Epidemiol Immunobiol; 1978 Jun; (6):66-71. PubMed ID: 354289
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prospective study of systemic and mucosal immune responses in dysenteric patients to specific Shigella invasion plasmid antigens and lipopolysaccharides.
    Oberhelman RA; Kopecko DJ; Salazar-Lindo E; Gotuzzo E; Buysse JM; Venkatesan MM; Yi A; Fernandez-Prada C; Guzman M; León-Barúa R
    Infect Immun; 1991 Jul; 59(7):2341-50. PubMed ID: 2050402
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Development, Interlaboratory Evaluations, and Application of a Simple, High-Throughput
    Nahm MH; Yu J; Weerts HP; Wenzel H; Tamilselvi CS; Chandrasekaran L; Pasetti MF; Mani S; Kaminski RW
    mSphere; 2018 Jun; 3(3):. PubMed ID: 29898979
    [No Abstract]   [Full Text] [Related]  

  • 35. [Liquid-phase electrophoresis in the analysis of antigen-antibody interactions in erythrocyte diagnostic reagent kits].
    Ivanov AIu; Miroshnikov AI
    Zh Mikrobiol Epidemiol Immunobiol; 1983 Jun; (6):115-8. PubMed ID: 6351504
    [No Abstract]   [Full Text] [Related]  

  • 36. Antibody response of monkeys to invasion plasmid antigen D after infection with Shigella spp.
    Oaks EV; Picking WD; Picking WL
    Clin Diagn Lab Immunol; 1996 Mar; 3(2):242-5. PubMed ID: 8991646
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [New directions in the study of immunity in dysentery].
    Pokrovskiĭ VI; Godovannyĭ BA; Iushchuk ND
    Zh Mikrobiol Epidemiol Immunobiol; 1983 Apr; (4):6-12. PubMed ID: 6346759
    [No Abstract]   [Full Text] [Related]  

  • 38. Immunogenicity of multivalent Shigella-ETEC candidate vaccine strains in a guinea pig model.
    Barry EM; Wang J; Wu T; Davis T; Levine MM
    Vaccine; 2006 May; 24(18):3727-34. PubMed ID: 16169130
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [The excretion of Shigella antigens in persons recovering from dysentery].
    Erkinbekova BK; Karal'nik BV; Aleshin AI; Nurkina NM
    Zh Mikrobiol Epidemiol Immunobiol; 1992; (5-6):21-4. PubMed ID: 1455962
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Shigella sonnei vaccine candidates WRSs2 and WRSs3 are as immunogenic as WRSS1, a clinically tested vaccine candidate, in a primate model of infection.
    Barnoy S; Baqar S; Kaminski RW; Collins T; Nemelka K; Hale TL; Ranallo RT; Venkatesan MM
    Vaccine; 2011 Aug; 29(37):6371-8. PubMed ID: 21596086
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.